Colorectal Carcinoma: Diagnostic, Prognostic, and Molecular Features

Fleming, 1997, AJCC manual for staging of cancer

Nelson, 1921, Guidelines for colon and rectal cancer surgery, J Natl Cancer Inst, 93, 583, 10.1093/jnci/93.8.583

Greene, 2002, AJCC manual for staging of cancer, 10.1007/978-1-4757-3656-4

Compton, 2000, Prognostic factors in colorectal cancer: College of American Pathologists Consensus Statement 1999, Arch Pathol Lab Med, 124, 979, 10.5858/2000-124-0979-PFICC

Compton, 2000, American Joint Committee on Cancer Prognostic Factors consensus conference: Colorectal Working Group, Cancer, 88, 1739, 10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO;2-T

Hamilton, 2000, Carcinoma of the colon and rectum, World Health Organization classification of tumours. Tumours of the digestive system, 101

Compton, 2000, Updated protocol for the examination of specimens removed from patients with colorectal carcinoma, Arch Pathol Lab Med, 124, 1016, 10.5858/2000-124-1016-UPFTEO

Jass, 1998, Morphology of sporadic colorectal cancer with DNA replication errors, Gut, 42, 673, 10.1136/gut.42.5.673

Messerini, 1997, Microsatellite instability in sporadic colorectal carcinomas: relationship to clinico-pathological variables, J Pathol, 182, 380, 10.1002/(SICI)1096-9896(199708)182:4<380::AID-PATH871>3.0.CO;2-U

Jesserun, 1999, Medullary adenocarcinoma of the colon: clinicopathologic study of 11 cases, Hum Pathol, 30, 843, 10.1016/S0046-8177(99)90146-6

Mulcahy, 1996, Long-term outcome following curative surgery for malignant large bowel obstruction, Br J Surg, 83, 46, 10.1002/bjs.1800830114

DeBruine, 1993, Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance, Int J Cancer, 54, 765, 10.1002/ijc.2910540510

Gaffey, 1990, Neuroendocrine carcinoma of the colon and rectum. A clinicopathologic, ultrastructural, and immunohistochemical study of 24 cases, Am J Surg Pathol, 14, 1010, 10.1097/00000478-199011000-00003

Goldstein, 1999, Am J Clin Pathol, 111, 51, 10.1093/ajcp/111.1.51

Shepherd, 1997, The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation, Gastroenterology, 112, 1096, 10.1016/S0016-5085(97)70119-7

Zeng, 1992, Serosal cytologic study to determine free mesothelial penetration of intraperitoneal colon cancer, Cancer, 70, 737, 10.1002/1097-0142(19920815)70:4<737::AID-CNCR2820700404>3.0.CO;2-S

Wittekind, 2001, TNM supplement. A commentary on uniform use

Herrera-Ornelas, 1987, Metastases in small lymph nodes from colon cancer, Arch Surg, 122, 1253, 10.1001/archsurg.1987.01400230039006

Scott, 1989, Detection of lymph node metastases in colorectal carcinoma before and after fat clearance, Br J Surg, 76, 1165, 10.1002/bjs.1800761118

Tepper, 2001, Impact of number of nodes retrieved on outcome in patients with rectal cancer, J Clin Oncol, 19, 157, 10.1200/JCO.2001.19.1.157

Blenkinsopp, 1981, Histopathology reporting in large bowel cancer, J Clin Pathol, 34, 509, 10.1136/jcp.34.5.509

Bernini, 2000, Evidence for colorectal cancer micrometastases using reverse transcriptase-polymerase chain reaction analysis of MUC2 in lymph nodes, Cancer Detect Prev, 24, 72

Liefers, 1999, Molecular detection of minimal residual disease in colorectal and breast cancer, Histopathology, 34, 385, 10.1046/j.1365-2559.1999.00716.x

Liefers, 1998, Micrometastases and survival in stage II colorectal cancer, N Engl J Med, 339, 223, 10.1056/NEJM199807233390403

Yasuda, 2001, Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer, Ann Surg Oncol, 8, 300, 10.1007/s10434-001-0300-5

Clarke, 2000, The detection of cytokeratins in lymph nodes of Duke's B colorectal cancer subjects predicts a poor outcome, Eur J Gastroenterol Hepatol, 12, 549, 10.1097/00042737-200012050-00012

Clarke, 1999, Immunohistochemical detection of mutant p53 protein in regional lymph nodes is associated with adverse outcome in stage II colorectal cancer, Eur J Histochem, 43, 311

Isaka, 1999, Prognostic significance of perirectal lymph node micrometastases in Dukes' B rectal carcinoma: an immunohistochemical study by CAM5.2, Clin Cancer Res, 5, 2065

Greenson, 1994, Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival, Cancer, 73, 563, 10.1002/1097-0142(19940201)73:3<563::AID-CNCR2820730311>3.0.CO;2-D

Clarke, 2001, Tumour-derived mutated K-ras, Int J Colorectal Dis, 16, 108, 10.1007/s003840100291

Tschmelitsch, 2000, Lymph node micrometastases do not predict relapse in stage II colon cancer, Ann Surg Oncol, 7, 601, 10.1007/BF02725340

Nakanishi, 1999, Clinical implications of lymph node micrometastases in patients with colorectal cancers. A case control study, Oncology, 57, 276, 10.1159/000012060

Oberg, 1998, Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer, Dis Colon Rectum, 41, 1244, 10.1007/BF02258221

Adell, 1996, Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study, Eur J Surg, 162, 637

Wittekind, 2002, Residual tumour classification revisited, Cancer, 94, 2511, 10.1002/cncr.10492

Cross, 1989, Is there any justification for the routine examination of bowel resection margins in colorectal adenocarcinoma, J Clin Pathol, 42, 1040, 10.1136/jcp.42.10.1040

Sloane, 1998, Standards and minimum datasets for reporting common cancers. Minimum dataset for colorectal cancer histopathology reports

Quirke, 2001, Limitations of existing systems of staging for rectal cancer: the forgotten margin, Rectal cancer research, 63

Quirke, 1992, The pathologist's role in the assessment of local recurrence in rectal carcinoma, Surg Oncol Clin N Am, 3, 1, 10.1016/S1055-3207(18)30619-7

Quirke, 1986, Local recurrence of rectal adenocarcinoma due to inadequate surgical resection, Lancet, II, 996, 10.1016/S0140-6736(86)92612-7

Adam, 1994, Role of the circumferential margin involvement in the local recurrence of rectal cancer, Lancet, 344, 707, 10.1016/S0140-6736(94)92206-3

Chan, 1985, A method of reporting radial invasion and surgical clearance of rectal carcinoma, Histopathology, 9, 1319, 10.1111/j.1365-2559.1985.tb02813.x

Stacchi, 2001, Impact of surgical and pathological variables in rectal cancer: a United States community and cooperative group report, J Clin Oncol, 19, 3895, 10.1200/JCO.2001.19.18.3895

Nagtegaal, 2002, Macroscopic evaluation of rectal cancer resection specimens: clinical significance of the pathologist in quality control, J Clin Oncol, 20, 1729, 10.1200/JCO.2002.07.010

Compton, 1999, The pathology report in colon cancer: what's prognostically important, Dig Dis, 17, 67, 10.1159/000016908

Jass, 1986, The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases, Histopathology, 10, 437, 10.1111/j.1365-2559.1986.tb02497.x

Hase, 1993, Prognostic value of tumor “budding” in patients with colorectal cancer, Dis Colon Rectum, 36, 627, 10.1007/BF02238588

Jass, 1998, Morphology of sporadic colorectal cancer with DNA replication errors, Gut, 42, 673, 10.1136/gut.42.5.673

Alexander, 2001, Histopathological identification of colon cancer with microsatellite instability, Am J Pathol, 158, 527, 10.1016/S0002-9440(10)63994-6

Jen, 1994, Allelic loss of chromosome 18q and prognosis in colorectal cancer, N Engl J Med, 331, 213, 10.1056/NEJM199407283310401

Laurent-Puig, 1992, Survival and acquired genetic alterations in colorectal cancer, Gastroenterology, 102, 1136, 10.1016/0016-5085(92)90749-O

Cohn, 1997, The significance of allelic deletions and aneuploidy in colorectal carcinoma, Cancer, 79, 233, 10.1002/(SICI)1097-0142(19970115)79:2<233::AID-CNCR6>3.0.CO;2-L

Carethers, 1998, Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer, Gastroenterology, 114, 1188, 10.1016/S0016-5085(98)70424-X

Gryfe, 2000, Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer, N Engl J Med, 342, 69, 10.1056/NEJM200001133420201

Sankila, 1996, Better survival rates in patients with MLH1-associated hereditary colorectal cancer, Gastroenterology, 110, 682, 10.1053/gast.1996.v110.pm8608876

Watanabe, 2001, Molecular predictors of survival after adjuvant chemotherapy for colon cancer, N Engl J Med, 344, 1196, 10.1056/NEJM200104193441603

Guidoboni, 2001, Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis, Am J Pathol, 159, 297, 10.1016/S0002-9440(10)61695-1

Samowitz, 2001, Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level, Cancer Epidemiol Biomarkers Prev, 10, 917

Berger, 1985, Thymidylate synthase overproduction and gene amplification in fluorodeoxyuridine-resistant human cells, Mol Pharmacol, 28, 461

Swain, 1989, Fluorouracil and high doses leucovorin in previously treated patients with metastatic breast cancer, J Clin Oncol, 7, 890, 10.1200/JCO.1989.7.7.890

Leichman, 1995, Quantitation of intratumoral thymidylate synthase expression predicts for resistance to protracted infusion of 5-fluorouracil and weekly leucovorin in disseminated colorectal cancers: preliminary report from an ongoing trial, Eur J Cancer, 31, 1306, 10.1016/0959-8049(95)00326-E